Ozanne S E, Jensen C B, Tingey K J, Martin-Gronert M S, Grunnet L, Brons C, Storgaard H, Vaag A A
Department of Clinical Biochemistry, Addenbrooke's Hospital, Level 4, Cambridge, UK.
Diabetologia. 2006 Dec;49(12):2993-9. doi: 10.1007/s00125-006-0466-2. Epub 2006 Oct 25.
AIMS/HYPOTHESIS: Individuals with low birthweight are at increased risk of type 2 diabetes mellitus. However, the underlying molecular mechanisms are unknown. Previously we have shown that low birthweight is associated with changes in muscle insulin signalling proteins. Here we determined whether low birthweight is associated with changes in insulin signalling proteins in adipose tissue.
Men (age 23 years) with either a low (bottom 10th percentile) (n = 17) or a normal (50th-90th percentile) (n = 17) birthweight were recruited from the Danish Medical Birth Registry and subcutaneous adipose biopsies were taken.
Between the two groups there was no difference in protein level of the insulin receptor, protein kinase C zeta, glycogen synthase kinase-3 (GSK3) alpha, GSK3 beta, protein kinase B alpha and beta, peroxisome proliferative activated receptor gamma coactivator 1 or Src-homology-2-containing protein. However, the levels of GLUT4 (also known as solute carrier family 2 [facilitated glucose transporter], member 4 [SLC2A4]) (52 +/- 10.9% reduction, p < 0.01), p85alpha subunit of phosphoinositide 3-kinase (PI3K) (45 +/- 9% reduction, p < 0.01), p110ss subunit of PI3K (48 +/- 17% reduction, p = 0.06) and IRS1 (59 +/- 24% reduction, p < 0.05) were reduced in men of low birthweight.
CONCLUSIONS/INTERPRETATION: These findings show that low birthweight is associated with reduced levels of adipose insulin signalling proteins, thus providing a potential molecular framework to explain why people with low birthweight are at increased risk of developing type 2 diabetes. These differences precede the development of diabetes and thus may help predict disease risk.
目的/假设:低出生体重个体患2型糖尿病的风险增加。然而,其潜在的分子机制尚不清楚。此前我们已表明,低出生体重与肌肉胰岛素信号蛋白的变化有关。在此,我们确定低出生体重是否与脂肪组织中胰岛素信号蛋白的变化有关。
从丹麦医学出生登记处招募出生体重低(处于第10百分位数以下)(n = 17)或正常(第50 - 90百分位数)(n = 17)的23岁男性,并采集皮下脂肪活检样本。
两组之间胰岛素受体、蛋白激酶C ζ、糖原合酶激酶-3(GSK3)α、GSK3 β、蛋白激酶B α和β、过氧化物酶体增殖物激活受体γ共激活因子1或含Src同源2结构域蛋白的蛋白质水平无差异。然而,低出生体重男性中葡萄糖转运蛋白4(也称为溶质载体家族2 [易化葡萄糖转运体],成员4 [SLC2A4])水平降低(降低52 ± 10.9%,p < 0.01),磷脂酰肌醇3激酶(PI3K)的p85α亚基水平降低(降低45 ± 9%,p < 0.01),PI3K的p110β亚基水平降低(降低48 ± 17%,p = 0.06),胰岛素受体底物1(IRS1)水平降低(降低59 ± 24%,p < 0.05)。
结论/解读:这些发现表明,低出生体重与脂肪胰岛素信号蛋白水平降低有关,从而提供了一个潜在的分子框架来解释为什么低出生体重人群患2型糖尿病的风险增加。这些差异在糖尿病发生之前就已存在,因此可能有助于预测疾病风险。